CanSino Biologics, Inc. Class H (HK:6185) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CanSino Biologics Inc. has announced the composition of its board of directors, which includes Dr. Xuefeng YU as Chairman and Executive Director, alongside other executive, non-executive, and independent directors. The company also disclosed the structure of its three Board committees—Audit, Remuneration and Assessment, and Nomination—with details on each member’s committee roles.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
